Heart function decline after stroke
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Stroke group: (1) Clinical reference was made to the ''Clinical Neurological Defect Degree Scoring Standards for Stroke Patients'' passed by the Fourth National Cerebrovascular Disease Academic Conference, the ICD-10 disease code of stroke confirmed by CT is I60, I61, I63 or I64, and the disease is stable; (2) Within 6 months of the disease course; (3) Aged 18-65 years; (4) It has the ability to change the posture of sitting and standing, and can use the sitting power car; (5) The score of the Simple Mental State Examination Scale>24, with the ability to understand the test steps and meaning; (6) Possess certain language communication skills and can communicate normally during the test; (7) Sign the informed consent. 2. Control group: (1) Good health and no cerebrovascular disease; (2) Aged 18-65 years; (3) It has the ability to change the posture of sitting and standing, and can use the sitting power car; (4) The score of the Simple Mental State Examination Scale>24, with the ability to understand the test steps and meaning; (5) Have certain language communication skills, and can communicate normally during the test; (6) Sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Unstable vital signs, including resting state: respiratory rate >=35 times/min; SpO2=120 beats/min or =180mmHg or =110mmHg; body temperature >=38.5? or =200U/L, or aspartate aminotransferase AST>=200U/L; 5. Patients with other serious diseases, such as malignant tumors, end-stage chronic kidney disease, mental disorders, severe malnutrition, uncontrolled metabolic diseases such as diabetes, pulmonary embolism, severe lung diseases (asthma, COPD), etc.; 6. Those with unhealed lower extremity fractures and severe osteoporosis; those with high muscle tension and Ashworth grade 2-4; 7. Peripheral vascular disease restricting exercise; 8. Patients with severe mental disorders; 9. Pregnant or lactating patients; 10. Participated in other clinical trials of drugs or medical devices during the same period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| peak oxygen consumption; | — |
Secondary
| Measure | Time frame |
|---|---|
| minute ventilation volume;ventilatory equivalent for carbon dioxide; | — |
Countries
China
Contacts
Shenzhen Second People's Hospital